Crompton and van der Waart et al. have shown that reduction of Akt activation during T cell ex vivo expansion resulted in potent tumor-infiltrating lymphocytes (TIL) and T cells specific for minor histocompatibility antigens (MiHAs) on tumors [15, 16]. This evidence concerns the gene AKT1 and neoplasm.